Book contents
- Treatment of Dystonia
- Treatment of Dystonia
- Copyright page
- Contents
- Contributors
- Preface
- 1 Development of the Concept of Dystonia as a Disease, a Syndrome and a Movement Phenomenology
- Section I Basics
- Section II Botulinum Toxin Therapy
- 21 The Global Market for Botulinum Toxin
- 22 Molecular Mechanisms of Botulinum Toxin
- 23 Indirect Central Nervous System Effects of Botulinum Toxin
- 24 Direct Central Nervous System Effects of Botulinum Neurotoxin
- 25 Analgesic Effects of Botulinum Toxins
- 26 Manufacture of Commercial Botulinum Neurotoxins for Human Treatment
- 27 Pharmacology of Botulinum Toxins
- 28 Immunology of Botulinum Toxin Therapy
- 29 Use of Non-A/Non-B Botulinum Toxins
- 30 Clinical Muscular Anatomy for the Botulinum Toxin Injector
- 31 Ultrasound Guidance for Botulinum Toxin Application
- 32 Treatment Algorithms and Injection Schemes for Botulinum Toxin Therapy of Dystonia
- 33 Botulinum Toxin Therapy for Cervical Dystonia
- 34 Botulinum Toxin Therapy for Cranial Dystonia
- 35 Botulinum Toxin Therapy for Spasmodic Dysphonia
- 36 Botulinum Toxin Therapy for Writer’s Cramp and Other Focal Hand Dystonias
- 37 Botulinum Toxin Therapy for Bruxism
- 38 Treatment of Blepharospasm With Eyelid-Opening Apraxia
- 39 Organisation of a Botulinum Toxin Clinic
- Section III Musician’s Dystonia
- Section IV Psychogenic Dystonia
- Section V Treatment of Paediatric Dystonia
- Section VI Rehabilitation of Dystonia
- Section VII Pharmacotherapy for Dystonia
- Section VIII Surgical Treatment of Dystonia
- Section IX Deep Brain Stimulation for Dystonia
- Section X Emerging Therapies for Dystonia
- Section XI Future Trends in Dystonia Therapy
- Book part
- Index
- References
24 - Direct Central Nervous System Effects of Botulinum Neurotoxin
from Section II - Botulinum Toxin Therapy
Published online by Cambridge University Press: 31 May 2018
Book contents
- Treatment of Dystonia
- Treatment of Dystonia
- Copyright page
- Contents
- Contributors
- Preface
- 1 Development of the Concept of Dystonia as a Disease, a Syndrome and a Movement Phenomenology
- Section I Basics
- Section II Botulinum Toxin Therapy
- 21 The Global Market for Botulinum Toxin
- 22 Molecular Mechanisms of Botulinum Toxin
- 23 Indirect Central Nervous System Effects of Botulinum Toxin
- 24 Direct Central Nervous System Effects of Botulinum Neurotoxin
- 25 Analgesic Effects of Botulinum Toxins
- 26 Manufacture of Commercial Botulinum Neurotoxins for Human Treatment
- 27 Pharmacology of Botulinum Toxins
- 28 Immunology of Botulinum Toxin Therapy
- 29 Use of Non-A/Non-B Botulinum Toxins
- 30 Clinical Muscular Anatomy for the Botulinum Toxin Injector
- 31 Ultrasound Guidance for Botulinum Toxin Application
- 32 Treatment Algorithms and Injection Schemes for Botulinum Toxin Therapy of Dystonia
- 33 Botulinum Toxin Therapy for Cervical Dystonia
- 34 Botulinum Toxin Therapy for Cranial Dystonia
- 35 Botulinum Toxin Therapy for Spasmodic Dysphonia
- 36 Botulinum Toxin Therapy for Writer’s Cramp and Other Focal Hand Dystonias
- 37 Botulinum Toxin Therapy for Bruxism
- 38 Treatment of Blepharospasm With Eyelid-Opening Apraxia
- 39 Organisation of a Botulinum Toxin Clinic
- Section III Musician’s Dystonia
- Section IV Psychogenic Dystonia
- Section V Treatment of Paediatric Dystonia
- Section VI Rehabilitation of Dystonia
- Section VII Pharmacotherapy for Dystonia
- Section VIII Surgical Treatment of Dystonia
- Section IX Deep Brain Stimulation for Dystonia
- Section X Emerging Therapies for Dystonia
- Section XI Future Trends in Dystonia Therapy
- Book part
- Index
- References
Summary
A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
- Type
- Chapter
- Information
- Treatment of Dystonia , pp. 111 - 114Publisher: Cambridge University PressPrint publication year: 2018
References
Antonucci, F, Rossi, C, Gianfranceschi, L, Rossetto, O, Caleo, M (2008). Long-distance retrograde effects of botulinum neurotoxin A. J Neurosci 28:3689–3696.CrossRefGoogle ScholarPubMed
Aymard, C, Giboin, LS, Lackmy-Vallee, A, Marchand-Pauvert, V (2013). Spinal plasticity in stroke patients after botulinum neurotoxin A injection in ankle plantar flexors. Physiol Rep 1:e00173.CrossRefGoogle ScholarPubMed
Bomba-Warczak, E, Vevea, JD, Brittain, JM, Figueroa-Bernier, A, Tepp, WH, Johnson, EA, Yeh, FL, Chapman, ER (2016). Interneuronal transfer and distal action of tetanus toxin and botulinum neurotoxins A and D in central neurons. Cell Rep 16:1974–1987.CrossRefGoogle Scholar
Brink, EE, Suzuki, I (1987). Recurrent inhibitory connexions among neck motoneurones in the cat. J Physiol 383:301–326.CrossRefGoogle ScholarPubMed
Giladi, N (1997). The mechanism of action of botulinum toxin type A in focal dystonia is most probably through its dual effect on efferent (motor) and afferent pathways at the injected site. J Neurol Sci 152:132–135.CrossRefGoogle ScholarPubMed
Hallett, M (2011). Neurophysiology of dystonia: the role of inhibition. Neurobiol Dis 42:177–184.CrossRefGoogle ScholarPubMed
Koizumi, H, Goto, S, Okita, S, Morigaki, R, Akaike, N, Torii, Y, Harakawa, T, Ginnaga, A, Kaji, R (2014). Spinal central effects of peripherally applied botulinum neurotoxin A in comparison between its subtypes A1 and A2. Front Neurol 5:98.CrossRefGoogle ScholarPubMed
Marchand-Pauvert, V, Iglesias, C (2008). Properties of human spinal interneurones: normal and dystonic control. J Physiol 586:1247–1256.CrossRefGoogle ScholarPubMed
Marchand-Pauvert, V, Aymard, C, Giboin, LS, Dominici, F, Rossi, A, Mazzocchio, R (2013). Beyond muscular effects: depression of spinal recurrent inhibition after botulinum neurotoxin A. J Physiol 591:1017–1029.Google Scholar
Matak, I, Lackovic, Z (2014). Botulinum toxin A, brain and pain. Prog Neurobiol 119–120:39–59.CrossRefGoogle ScholarPubMed
Matsuo, K, Ban, R, Ban, M, Yuzuriha, S (2014). Trigeminal proprioception evoked by strong stretching of the mechanoreceptors in Muller’s muscle induces reflex contraction of the orbital orbicularis oculi slow-twitch muscle fibers. Eplasty 14:e30.Google ScholarPubMed
Mazzocchio, R, Caleo, M (2015). More than at the neuromuscular synapse: actions of botulinum neurotoxin A in the central nervous system. Neuroscientist 21:44–61.Google Scholar
Moreno-Lopez, B, Pastor, AM, de la Cruz, RR, Delgado-Garcia, JM (1997). Dose-dependent, central effects of botulinum neurotoxin type A: a pilot study in the alert behaving cat. Neurology 48:456–464.CrossRefGoogle ScholarPubMed
Pastor, AM, Moreno-Lopez, B, De La Cruz, RR, Delgado-Garcia, JM (1997). Effects of botulinum neurotoxin type A on abducens motoneurons in the cat: ultrastructural and synaptic alterations. Neuroscience 81:457–478.Google Scholar
Priori, A, Berardelli, A, Mercuri, B, Manfredi, M (1995). Physiological effects produced by botulinum toxin treatment of upper limb dystonia: changes in reciprocal inhibition between forearm muscles. Brain 118 (Pt 3):801–807.CrossRefGoogle ScholarPubMed
Ramachandran, R, Lam, C, Yaksh, TL (2015). Botulinum toxin in migraine: role of transport in trigemino-somatic and trigemino-vascular afferents. Neurobiol Dis 79:111–122.Google Scholar
Restani, L, Giribaldi, F, Manich, M, Bercsenyi, K, Menendez, G, Rossetto, O, Caleo, M, Schiavo, G (2012a). Botulinum neurotoxins A and E undergo retrograde axonal transport in primary motor neurons. PLoS Pathog 8:e1003087.CrossRefGoogle Scholar
Restani, L, Novelli, E, Bottari, D, Leone, P, Barone, I, Galli-Resta, L, Strettoi, E, Caleo, M (2012b). Botulinum neurotoxin A impairs neurotransmission following retrograde transynaptic transport. Traffic 13:1083–1089.CrossRefGoogle ScholarPubMed
Rossetto, O, Pirazzini, M, Montecucco, C (2015). Current gaps in basic science knowledge of botulinum neurotoxin biological actions. Toxicon 107(Pt A):59–63.Google Scholar
Salinas, S, Schiavo, G, Kremer, EJ (2010). A hitchhiker’s guide to the nervous system: the complex journey of viruses and toxins. Nat Rev Microbiol 8:645–655.Google Scholar
Valls-Sole, J, Tolosa, ES, Ribera, G (1991). Neurophysiological observations on the effects of botulinum toxin treatment in patients with dystonic blepharospasm. J Neurol Neurosurg Psychiatry 54:310–313.CrossRefGoogle ScholarPubMed
Verderio, C, Pozzi, D, Pravettoni, E, Inverardi, F, Schenk, U, Coco, S, Proux-Gillardeaux, V, Galli, T, Rossetto, O, Frassoni, C, Matteoli, M (2004). SNAP-25 modulation of calcium dynamics underlies differences in GABAergic and glutamatergic responsiveness to depolarization. Neuron 41:599–610.CrossRefGoogle ScholarPubMed
Wang, T, Martin, S, Papadopulos, A, Harper, CB, Mavlyutov, TA, Niranjan, D, Glass, NR, Cooper-White, JJ, Sibarita, JB, Choquet, D, Davletov, B, Meunier, FA (2015). Control of autophagosome axonal retrograde flux by presynaptic activity unveiled using botulinum neurotoxin type A. J Neurosci 35:6179–6194.Google Scholar